How to Fix Tachycardia: Immediate and Long-Term Options

Treating tachycardia depends entirely on what kind you have, what is causing it, and how urgently it needs to stop. Some episodes can be broken in seconds with a simple breathing technique you perform yourself, while others require medications, electrical shocks, or procedures that permanently rewire the heart’s electrical system. The range of options spans from free, at-home maneuvers to implantable devices that monitor your heart around the clock, and choosing the right approach starts with understanding the situation you are actually in.

Stopping an Episode Right Now

If your heart suddenly races and you are conscious, alert, and not lightheaded enough to pass out, the standard first move is a vagal maneuver. These are physical actions that stimulate the vagus nerve, which slows electrical conduction through the heart. The classic version is the Valsalva maneuver: you bear down as if straining on the toilet, holding that effort for about 15 seconds. It works, but not reliably. A modified version has shown dramatically better results. In the modified Valsalva, you perform the same strain while sitting semi-reclined, then immediately lie flat and have someone lift your legs to about a 45-degree angle for another 15 seconds. A meta-analysis found this modified approach converted the heart back to normal rhythm about three times as often as the standard technique.¹ A separate systematic review reported that the modified maneuver succeeded in roughly half of patients, compared with under a fifth for the standard version, with no serious side effects in either group.²

Other vagal maneuvers include pressing on your carotid sinus (on one side of the neck, never both), dunking your face in ice water, or coughing forcefully. These all aim to jolt the vagus nerve into action. They work best for supraventricular tachycardias, the kind that originate above the heart’s ventricles and are the most common cause of sudden-onset racing in otherwise healthy people. The modified Valsalva is now recommended as the first-line intervention in stable patients because it is free, safe, reproducible, and cuts the need for emergency drugs.³

When You End Up in the Emergency Room

If vagal maneuvers do not work, the next step in an emergency department is usually adenosine, a drug given as a rapid intravenous push. Adenosine briefly blocks electrical conduction at a critical junction in the heart, essentially resetting the circuit that is causing the rapid rhythm. It acts within seconds and wears off almost as fast. In one study of patients with unstable supraventricular tachycardia, every patient converted to a normal rhythm with adenosine, and none required electrical cardioversion. Most responded to a single dose; those who did not were successfully treated with a second, larger dose.⁴ The drug produces a brief, unsettling sensation — patients often describe a feeling of chest pressure or a moment where the heart seems to stop — but the discomfort passes quickly.

For patients who are hemodynamically unstable, meaning their blood pressure has dropped dangerously or they are losing consciousness, doctors may skip drugs and go straight to synchronized electrical cardioversion. This involves delivering a controlled electrical shock timed to a specific moment in the heart’s electrical cycle. It is highly effective but carries small risks, which is why it is reserved for situations where speed matters more than comfort. Sedation is given first whenever possible.

Ventricular tachycardia, a more dangerous rhythm originating in the lower chambers, follows a different emergency playbook. If the patient has a pulse, intravenous amiodarone or lidocaine may be used. If they do not have a pulse, defibrillation is immediate and non-negotiable. For cases of ventricular fibrillation or pulseless ventricular tachycardia that resist standard shocks, some centers are exploring strategies like double sequential defibrillation to improve survival.⁵

Daily Medications for Ongoing Control

When tachycardia keeps coming back, medications taken daily can reduce how often episodes happen and how fast the heart goes during them. Beta-blockers are the workhorse of this category. They dampen the effect of adrenaline on the heart, slowing the resting rate and blunting the heart’s tendency to race under stress. Research over decades has established that beta-blockers prevent life-threatening ventricular arrhythmias and reduce the risk of sudden death, particularly in people who have had a heart attack.⁶

Calcium channel blockers like verapamil and diltiazem are another option, especially for supraventricular tachycardias. They slow conduction through the AV node, the electrical gateway between the upper and lower chambers. Antiarrhythmic drugs like flecainide, propafenone, sotalol, or amiodarone target the electrical properties of heart cells more directly, but they come with more side effects and sometimes the paradoxical risk of causing new arrhythmias. The choice of drug depends heavily on which type of tachycardia you have, whether you have structural heart disease, and what your kidneys and liver can handle.

Medications can be effective, but they rarely cure tachycardia outright. They manage it. For many people, the calculus becomes whether it is worth taking a daily pill indefinitely or pursuing a procedure that may eliminate the arrhythmia altogether.

Catheter Ablation

Catheter ablation is the closest thing to a cure for many types of tachycardia. A cardiologist threads thin, flexible wires through a vein (usually in the groin) up into the heart, identifies the exact spot where the abnormal electrical signal originates or circulates, and destroys that tiny patch of tissue with heat (radiofrequency energy) or extreme cold (cryoablation). The damaged tissue can no longer conduct the rogue signal, and the tachycardia stops.

For conditions like Wolff-Parkinson-White syndrome, where an extra electrical pathway connects the upper and lower chambers, ablation is remarkably effective. A meta-analysis of over 2,200 patients found a success rate above 94%, a recurrence rate around 6%, and a complication rate of about 1%.⁷ For AVNRT, the most common type of supraventricular tachycardia, success rates are similarly high. These are the kinds of results that make ablation a first-line option for people who have frequent, bothersome episodes rather than a last resort after medications fail.

Atrial fibrillation ablation is a different story. The procedure centers on electrically isolating the pulmonary veins, which are the main source of the erratic signals that drive atrial fibrillation. The challenge is making the isolation durable. When the tiny lesions heal and electrical connections reform, the arrhythmia tends to come back.⁸ In the CAPLA randomized trial, about half of patients with persistent atrial fibrillation remained free from arrhythmia recurrence at one year after a single procedure, regardless of whether additional tissue beyond the pulmonary veins was targeted.⁹ A roughly one-in-two success rate from a single session may not sound impressive compared to the 94% figure for Wolff-Parkinson-White, but many patients undergo a second or third procedure, and the cumulative success rate is higher. Newer techniques using ablation index technology to standardize how much energy is delivered at each point have improved outcomes, with one study showing about 71% of patients remaining arrhythmia-free compared to 62% with conventional approaches.¹⁰

Implantable Devices

For people at risk of sudden cardiac death from ventricular tachycardia or ventricular fibrillation, an implantable cardioverter-defibrillator (ICD) can be lifesaving. The device sits under the skin near the collarbone, with leads running into the heart. It continuously monitors the rhythm and can deliver a shock to terminate a dangerous arrhythmia within seconds, essentially serving as a personal emergency room on standby. ICDs have a proven survival benefit in selected patient groups and are more effective than any known antiarrhythmic drug at preventing sudden cardiac death.¹¹¹²

Living with an ICD is not without challenges. The shocks themselves can be painful and psychologically distressing, particularly inappropriate shocks triggered by non-dangerous rhythms. Modern ICDs are programmed to attempt anti-tachycardia pacing first, a painless sequence of rapid electrical pulses that can often terminate ventricular tachycardia before a shock is needed. Programming strategies continue to evolve to minimize unnecessary shocks while keeping life-saving therapy available.

Fixing the Underlying Cause

Sometimes the fastest heart rate is not the disease. It is a symptom of something else, and treating the tachycardia without addressing the root cause is like unplugging a smoke alarm instead of putting out the fire. An overactive thyroid gland is one of the most common reversible triggers. Hyperthyroidism floods the body with hormones that speed up metabolism and make the heart race, and sinus tachycardia and atrial fibrillation are the arrhythmias most frequently linked to it.¹³ Once thyroid levels are brought back to normal with medication, radioactive iodine, or surgery, the tachycardia often resolves on its own.

Other reversible causes include anemia, dehydration, fever, excessive caffeine or stimulant use, and certain medications. A thorough workup for someone with unexplained tachycardia typically includes thyroid function tests, a blood count, and a review of every substance going into their body. Skipping this step and jumping straight to rhythm-control drugs is a common clinical pitfall.

Sleep-disordered breathing, particularly obstructive sleep apnea, is increasingly recognized as a contributor to atrial fibrillation. An American Heart Association scientific statement noted that observational data suggest treating sleep apnea reduces atrial fibrillation recurrence after rhythm-control procedures, though high-level trial evidence confirming this is still limited.¹⁴ Despite the evidence gap, many electrophysiologists now screen for sleep apnea before performing atrial fibrillation ablation, reasoning that leaving it untreated undermines the procedure’s long-term success.

Inappropriate Sinus Tachycardia and POTS

Not every fast heart rate fits neatly into the categories above. Inappropriate sinus tachycardia (IST) is a frustrating condition where the heart’s natural pacemaker runs too fast for no identifiable reason. The resting heart rate exceeds 100 beats per minute, and it climbs higher than expected with even minimal activity. Patients feel palpitations, dizziness, and shortness of breath, yet standard tests often come back normal. Diagnosing IST requires ruling out a long list of other causes, including thyroid disease, anemia, medication effects, and other arrhythmias.¹⁵

Postural tachycardia syndrome (POTS) is a related but distinct condition where the heart rate spikes excessively upon standing, often by 30 beats per minute or more within ten minutes. Both IST and POTS involve dysfunction of the autonomic nervous system rather than a structural electrical short circuit. Treatment for both conditions generally starts with lifestyle changes like increasing fluid and salt intake, wearing compression garments, and graded exercise programs. When medications are needed, beta-blockers are tried first. Ivabradine, a drug that selectively slows the sinus node without lowering blood pressure, has emerged as a particularly effective option for IST and may be superior to beta-blockers for that specific condition.¹⁵ If these approaches fail, more aggressive interventions like sinus node modification can be considered, though they are reserved for severe, debilitating cases.¹⁶

Why Untreated Tachycardia Matters

There is a reason doctors push to get fast rhythms under control rather than simply telling patients to live with the occasional racing episode. Prolonged or frequent tachycardia can weaken the heart muscle itself, a condition called tachycardia-induced cardiomyopathy. The heart, forced to beat too fast for too long, becomes dilated and pumps less effectively. The encouraging part is that this damage is often reversible. Once the arrhythmia is controlled through cardioversion, medications, or ablation, the heart’s pumping function tends to improve substantially, sometimes returning to normal.¹⁷¹⁸ The diagnosis is usually made retrospectively: if the heart function bounces back after rate control, the arrhythmia was probably the culprit.

Atrial fibrillation carries the additional risk of stroke. Blood can pool in the fibrillating atria, form clots, and travel to the brain. Stroke risk is assessed using scoring systems, and depending on the score, long-term blood thinners may be recommended. One analysis found that newer scoring tools classified over half of atrial fibrillation patients as needing anticoagulation, compared with about a third under older scoring methods.¹⁹ This means the threshold for recommending blood thinners has shifted lower over time. Even if your atrial fibrillation episodes are infrequent or brief, the stroke risk may still warrant anticoagulation.

Catching What You Cannot Feel

One of the biggest obstacles in managing tachycardia is that episodes can be sporadic and short-lived. You might feel your heart race for 30 seconds and then have it settle before you can get to a doctor. A standard 12-lead ECG only captures about 10 seconds. Traditional 24-hour Holter monitors do better but still miss a lot if the arrhythmia does not happen to fire during that window. Longer-duration monitoring has changed the game. Patch-type ECG monitors worn for up to 14 days detected major arrhythmias in about 76% of patients, compared with 48% for standard Holter monitoring. For atrial fibrillation specifically, the detection rate was roughly double with extended patch monitoring.²⁰ A substantial portion of atrial fibrillation episodes were caught on the first day, but new cases continued to be detected steadily through the full two weeks of wear.

Consumer wearables like smartwatches with optical heart-rate sensors have added another layer of detection. They are not diagnostic on their own, but they can flag irregularities and prompt you to seek formal testing. For anyone with unexplained palpitations that come and go, asking your doctor about an extended monitor rather than accepting a normal Holter result is reasonable.

When Tachycardia and Anxiety Overlap

The relationship between fast heart rate and anxiety is a chicken-and-egg problem that trips up patients and doctors alike. Panic attacks cause a pounding heart. But supraventricular tachycardia also causes a pounding heart, along with chest tightness, shortness of breath, and a sense of doom, which are classic panic-attack symptoms. Patients with undiagnosed SVT sometimes spend years being treated for a psychiatric condition when the real problem is an electrical short circuit in the heart.²¹

The evidence that SVT can actually cause panic disorder, rather than just mimicking it, comes from cases where catheter ablation of the arrhythmia cured both the rapid heart rate and the panic episodes.²² The theory is that repeated episodes of unexplained racing trigger a learned fear response: your body associates the physical sensation with danger, and eventually the brain starts generating full-blown panic attacks around those sensations. Eliminating the trigger breaks the cycle. If you have been diagnosed with panic disorder and your episodes always begin with a sudden, rapid heart rate rather than building gradually from anxious thoughts, it is worth pushing for cardiac monitoring to rule out an arrhythmia.

Emerging Approaches

For patients whose tachycardia resists conventional catheter ablation or who are too sick to undergo an invasive procedure, a newer option is gaining ground. Stereotactic arrhythmia radioablation, or STAR, borrows technology from cancer radiation therapy. Using advanced imaging to map the heart’s electrical problem, a focused beam of radiation is aimed at the arrhythmogenic tissue from outside the body. No catheters, no anesthesia, no vascular access. Early clinical studies suggest it provides comparable results to catheter ablation with a favorable safety profile, positioning it as a potential alternative for patients who have run out of standard options.²³

Adults with congenital heart disease represent another group where tachycardia management is especially complex. Surgical repairs performed in childhood often leave scar tissue that becomes the substrate for arrhythmias decades later. Intra-atrial reentrant tachycardia and atrial fibrillation are the most common arrhythmias in this population, and treatment often involves a combination of electrophysiology studies, catheter ablation, and sometimes further surgical or catheter-based correction of the underlying structural problem.²⁴ Standard treatment algorithms developed for structurally normal hearts do not always apply here, and these patients benefit from care at specialized centers.